GOLD Learning Speakers

U.S.A.

Dr. Frank Nice, RPh, DPA,CPHP

  • Speaker Type: GOLD Lactation 2013, Webinars, GOLD Lactation 2014
  • Country: U.S.A.
Biography:

Dr. Frank J. Nice has practiced as a consultant, lecturer, and author on medications and breastfeeding for over 35 years. He holds a Bachelor’s Degree in Pharmacy, a Masters Degree in Pharmacy Administration, Masters and Doctorate Degrees in Public Administration, and Certification in Public Health Pharmacy. He practiced at the NIH for 30 years and currently serves as a project manager at the FDA.Dr. Nice has organized and participated in over a three dozen medical missions to the country of Haiti. He retired from the US Public Health Service after 30 years of distinguished service. Dr. Nice has published over three dozen peer-reviewed articles on the use of prescription medications, Over-the-Counter (OTC) products, and herbals during breastfeeding, in addition to articles and book chapters on the use of power, epilepsy, and work characteristics of health care professionals. He continues to provide consultations, lectures, and presentations to the breastfeeding community and to serve the poor of Haiti.

CE Library Presentation(s) Available Online:
Watch Today!
View Lecture
Note: Currently only available through a bundled series of lectures
Breastfeeding and Non-prescription Drugs
The use of nonprescription products by breastfeeding mothers is even more common than the use of prescription drugs. These products include Over-The-Counter (OTC) medications, herbal preparations, and dietary supplements. Because they are available for common and not-so-common maladies, there is an overwhelming and bewildering variety of nonprescription products available to consumers. Thus, there is always the possibility that a breastfed infant could receive medications through breast milk, just as with prescription drugs. The use of a nonprescription medication does not require a doctor’s prescription. Therefore, the decision to take a nonprescription medication is almost always made by the breastfeeding mother.Of course, family and friends may influence her decision as to choice. Pharmacists, doctors, and lactation consultants must be able to provide proper advice on the use or safety of nonprescription products during breastfeeding. The presentation on Breastfeeding and Nonprescription Drugs will provide the necessary information to do so.
Presentations: 19  |  Hours / CE Credits: 15  |  Viewing Time: 8 Weeks
Hours / CE Credits: 1 (details)  |  Categories: Breastfeeding and Lactation
Watch Today!
View Lecture
Note: Currently only available through a bundled series of lectures
Herbal and Pharmaceutical Galactogogues Use During Breastfeeding
Sources of information for prescription and nonprescription galactogogue use during breastfeeding will be presented and reviewed. Potential adverse effects in children of mothers who are breastfeeding and taking galactogogue medications will be reviewed and discussed. Various herbals that are used as galactogogues will be identified. Using the material presented, healthcare professionals will be able to counsel mothers who are breastfeeding and taking or will take galactogogue products (prescription, over-the counter, herbal, and complimentary).
Presentations: 1  |  Hours / CE Credits: 1  |  Viewing Time: 3 Weeks
Hours / CE Credits: 1 (details)  |  Categories:
Watch Today!
View Lecture
Note: Currently only available through a bundled series of lectures
Domperidone and Breastfeeding
Domperidone currently is used worldwide as an anti-nausea agent for adults, children, and women. It is currently available in 60 countries including Canada and Mexico. Domperidone was recently given orphan drug designation for the treatment of hypoprolactinemia in breastfeeding. Over 60,000 cases of hypoprolactinemia are reported annual in the United States. Infants who do not receive human milk cost the healthcare system over $13 billion each year and result in over 900 unnecessary infant deaths annually. Domperidone can produce significant increases in prolactin with subsequent increases in milk production. No drug is currently approved for the condition of hypoprolactinemia of lactation in any country. This presentation will describe and explain the Orphan Drug Act and the steps necessary for domperidone to receive approval under the Act. Prolactin facts will be discussed as well as a review of the rare disease, hypoprolactinemia. The scientific rationale for the use of domperidone will be covered. Practical information will be presented on domperidone dosing and withdrawal of the drug with sufficient milk supply and with insufficient milk supply.
Presentations: 28  |  Hours / CE Credits: 22.25  |  Viewing Time: 8 Weeks
Hours / CE Credits: 1 (details)  |  Categories: Breastfeeding and Lactation